This trial studies the impact of a 12-month invention focused on early detection of skin cancer and timely follow up in patients who underwent stem cell transplant and their primary care providers. Some stem cell transplant survivors may develop complications related to the treatment they received. Many of these complications may not be known for years after the treatment and preventive measures can be taken to reduce the chances that a complication will occur and encourage early detection. This study focuses on one complication that stem cell transplant survivors are at high risk of developing - skin cancer. An early diagnosis of skin cancer is important since the cancer is usually smaller, requires less extensive treatments, and has better outcomes. Teaching skin self-examination and encouraging patients to alert doctors to skin changes may provide an important opportunity for early detection of skin cancer.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Impact of patient activation and education alone or with physician activation on change in skin cancer screening and health promotion practices
Timeframe: Baseline and 12 months
Time interval between a participant's first notice of a suspect mole or lesion and the date on which a definitive diagnosis was made
Timeframe: Up to 12 months
Impact of an e-learning teledermoscopy program compared with provision of print materials for identifying suspect lesions
Timeframe: Up to 12 months
Economic impact on patients - cost-effectiveness analysis
Timeframe: Up to 12 months
Economic impact on patients - sensitivity analysis
Timeframe: Up to 12 months
Downstream costs
Timeframe: Up to 12 months